George Hill
Stock Analyst at Deutsche Bank
(2.95)
# 1,383
Out of 5,242 analysts
199
Total ratings
53.39%
Success rate
5.89%
Average return
Main Sectors:
Stocks Rated by George Hill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CI The Cigna Group | Downgrades: Hold | $303 → $302 | $291.28 | +3.68% | 11 | May 20, 2026 | |
| HUM Humana | Upgrades: Buy | $235 → $441 | $310.55 | +42.01% | 13 | May 20, 2026 | |
| CNC Centene | Upgrades: Buy | $53 → $80 | $59.15 | +35.25% | 11 | May 20, 2026 | |
| ELV Elevance Health | Upgrades: Buy | $363 → $498 | $402.27 | +23.80% | 4 | May 20, 2026 | |
| AGL agilon health | Upgrades: Buy | $33 → $49 | $88.20 | -44.44% | 17 | May 7, 2026 | |
| HQY HealthEquity | Maintains: Buy | $120 → $128 | $84.65 | +51.21% | 19 | Mar 19, 2026 | |
| WAY Waystar Holding | Maintains: Buy | $42 → $37 | $19.60 | +88.78% | 3 | Mar 12, 2026 | |
| TDOC Teladoc Health | Upgrades: Buy | $11 | $6.61 | +66.41% | 19 | Mar 10, 2026 | |
| HIMS Hims & Hers Health | Maintains: Hold | $25 → $28 | $22.44 | +24.78% | 5 | Mar 10, 2026 | |
| MCK McKesson | Maintains: Buy | $775 → $856 | $761.89 | +12.35% | 8 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $521 → $362 | $389.24 | -7.00% | 22 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $70 | $94.18 | -25.67% | 7 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $119 → $124 | $200.37 | -38.11% | 12 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $1.76 | +13.64% | 14 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $5 | $0.8711 | +473.99% | 4 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $353 | $184.38 | +91.45% | 9 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $461 → $471 | $221.93 | +112.23% | 2 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $8 | $2.52 | +217.46% | 5 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $255 → $250 | $173.18 | +44.36% | 4 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $287 → $235 | $113.55 | +106.96% | 5 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $334 | $152.43 | +119.12% | 5 | Feb 18, 2021 |
The Cigna Group
May 20, 2026
Downgrades: Hold
Price Target: $303 → $302
Current: $291.28
Upside: +3.68%
Humana
May 20, 2026
Upgrades: Buy
Price Target: $235 → $441
Current: $310.55
Upside: +42.01%
Centene
May 20, 2026
Upgrades: Buy
Price Target: $53 → $80
Current: $59.15
Upside: +35.25%
Elevance Health
May 20, 2026
Upgrades: Buy
Price Target: $363 → $498
Current: $402.27
Upside: +23.80%
agilon health
May 7, 2026
Upgrades: Buy
Price Target: $33 → $49
Current: $88.20
Upside: -44.44%
HealthEquity
Mar 19, 2026
Maintains: Buy
Price Target: $120 → $128
Current: $84.65
Upside: +51.21%
Waystar Holding
Mar 12, 2026
Maintains: Buy
Price Target: $42 → $37
Current: $19.60
Upside: +88.78%
Teladoc Health
Mar 10, 2026
Upgrades: Buy
Price Target: $11
Current: $6.61
Upside: +66.41%
Hims & Hers Health
Mar 10, 2026
Maintains: Hold
Price Target: $25 → $28
Current: $22.44
Upside: +24.78%
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $775 → $856
Current: $761.89
Upside: +12.35%
May 14, 2025
Maintains: Buy
Price Target: $521 → $362
Current: $389.24
Upside: -7.00%
Feb 14, 2025
Maintains: Buy
Price Target: $66 → $70
Current: $94.18
Upside: -25.67%
Nov 4, 2024
Maintains: Hold
Price Target: $119 → $124
Current: $200.37
Upside: -38.11%
Aug 14, 2024
Maintains: Hold
Price Target: $5 → $2
Current: $1.76
Upside: +13.64%
Aug 9, 2024
Maintains: Hold
Price Target: $7 → $5
Current: $0.8711
Upside: +473.99%
Jul 29, 2024
Maintains: Hold
Price Target: $354 → $353
Current: $184.38
Upside: +91.45%
Sep 5, 2023
Maintains: Buy
Price Target: $461 → $471
Current: $221.93
Upside: +112.23%
Aug 10, 2023
Maintains: Hold
Price Target: $6 → $8
Current: $2.52
Upside: +217.46%
Mar 23, 2022
Maintains: Buy
Price Target: $255 → $250
Current: $173.18
Upside: +44.36%
Feb 25, 2022
Maintains: Hold
Price Target: $287 → $235
Current: $113.55
Upside: +106.96%
Feb 18, 2021
Maintains: Buy
Price Target: $250 → $334
Current: $152.43
Upside: +119.12%